• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SI6

SI6 METALS LIMITED - Announcements

22.2% ! 2.2¢
Currently unlisted.
Add to My Watchlist

Corporate Spotlight


View the full Corporate Spotlight arrow Created with Sketch.

Announcements



Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
SI6 Quarterly Cashflow ReportPRICE SENSITIVE23/04/18
SI6 Quarterly Activities ReportPRICE SENSITIVE23/04/18
SI6 Quarterly Activities ReportPRICE SENSITIVE31/01/18
SI6 Quarterly Cashflow Report
23/04/18PRICE SENSITIVE
SI6 Quarterly Activities Report
23/04/18PRICE SENSITIVE
SI6 Quarterly Activities Report
31/01/18PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Australia's resources and energy exports remain strong, despite Middle East crisis

The AI investment boom is helping to generate demand for Australia’s resources and energy commodities according to new federal data.
Diablo: Horn Silver acquisition approved, maiden Star Range drilling set to commence Diablo Resources CEO Lyle Thorne joins HotCopper to discuss acquisition of the historic Horn Silver in Utah, as well as final drill permits.
Expert Exchange: David Sokulsky on AI trade, chip stocks, and where to invest now Carrara Capital CIO David Sokulsky on why he's bullish on AI but cautious on valuations, Nvidia, SK Hynix, and his top trading advice.
LISTEN: HotCopper Wire Podcast #052 – Finger lickin' not so good In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson talk about all the inflation data that’s come out in Australia this week and whether the Reserve Bank will go for another hike in August, as well as the H5 bird flu scare in WA @ and what t...
Syntara shows encouraging first signals it can impact the path to Parkinson's Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence that the company’s novel anti-inflammatory therapy may be targeting a key biological process linked to the development of Parkinson’...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.